Search through
2-[(Diphenylmethyl)sulfinyl]acetamide (CAS 68693-11-8) serves as a critical component in the United States API intermediates market, primarily utilized for the synthesis of wakefulness-promoting agents where a Pharma/API purity of 99% is required to meet stringent FDA standards. Benzhydrylsulfinylacetamide demand is currently being reshaped by significant domestic CDMO growth and a strategic pivot in global sourcing, as American manufacturers increasingly prioritize a domestic bulk chemical supplier to ensure supply chain resilience and maintain rigorous regulatory compliance. 2-(Benzhydrylsulfinyl)acetamide is increasingly sought through specialized custom synthesis services within the North American high purity fine chemicals sector to support the development of advanced neuropsychiatric formulations that require precise impurity profiling and consistent batch-to-batch quality. We are an established Modafinil api supplier with >= 99% purity for semi-finished formulators in the united states , providing comprehensive analytical (HPLC/NMR/MS) and supporting (Modafinil) COA/TDS/SDS region-specific regulatory support. reliable lead times, worldwide supply chain capabilities
2-[(Diphenylmethyl)sulfinyl]acetamide (CAS 68693-11-8) serves as a critical component in the United States API intermediates market, primarily utilized for the synthesis of wakefulness-promoting agents where a Pharma/API purity of 99% is required to meet stringent FDA standards. Benzhydrylsulfinylacetamide demand is currently being reshaped by significant domestic CDMO growth and a strategic pivot in global sourcing, as American manufacturers increasingly prioritize a domestic bulk chemical supplier to ensure supply chain resilience and maintain rigorous regulatory compliance. 2-(Benzhydrylsulfinyl)acetamide is increasingly sought through specialized custom synthesis services within the Nort...
.3d8f8f41.svg)
Pharmaceutical
.3556d45a.svg)
Pharmaceutical Actives & Precursors
Active Pharmaceutical Ingredients (APIs)
.7767eb0f.png)
Chemical Properties & Specifications
P201, P202, P260, P264, P270, P271, P280, P301+P312, P330, P304+P340, P308+P313, P314, P405, and P501
Repr. 2 (100%)
STOT RE 2 (100%)
A central nervous system stimulant indicated to improve wakefulness in adult patients with excessive sleepiness associated with narcolepsy, obstructive sleep apnea, or shift work disorder
A pharmaceutical nootropic agent used off-label to enhance executive functions such as planning, decision-making, and fluid intelligence in healthy individuals
A secondary treatment used alongside continuous positive airway pressure (CPAP) machines to manage residual daytime sleepiness in patients with obstructive sleep apnea
A clinical intervention used off-label to mitigate debilitating fatigue associated with medical conditions such as multiple sclerosis, major depressive disorder, and certain cancers.
Modafinil is a central nervous system stimulant and wakefulness-promoting agent used to treat excessive sleepiness caused by narcolepsy, shift work sleep disorder, and obstructive sleep apnea
This compound is primarily used in the pharmaceutical and healthcare industries for the treatment of sleep disorders and as an off-label cognitive enhancer
Modafinil is practically insoluble in water and is typically formulated as oral tablets, including fast-dissolving and direct-compression tablets
Standard specifications include CAS number 68693-11-8, high purity typically verified by HPLC, and documentation such as COA, TDS, impurity reports, and regulatory compliance documents
Scimplify has capabilities for global distribution and custom synthesis through an integrated network of manufacturers and logistics partners with reliable lead time
The product is export ready with a standard MOQ starting from 100 kgs, with lead times for international customers depending on the shipping destination and specific grade.
Category : Pharmaceutical Actives & Precursors
Sub-Category : Intermediates & Precursors
Description : P-Nitrobenzoyl Chloride (CAS 122-04-3) is a critical building block in the API intermediates market,...
